相关实验视频
Updated: Jun 16, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
亚洲人群中黑色素瘤分子研究和治疗的最新进展
Soichiro Kado1, Mayumi Komine1,2
1Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
International journal of molecular sciences
|June 13, 2025
概括
向治疗和免疫检查点抑制剂已经彻底改变了黑色素瘤治疗,改善了生存率. 然而,在亚洲人群中,耐药性和降低疗效等挑战需要进一步研究以实现全球优化.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 在向治疗和免疫治疗之前,黑色素瘤的治疗是有限的.
- BRAF/MEK 抑制剂和免疫检查点抑制剂 (抗PD-1,抗CTLA-4) 已成为护理的标准.
- 在改善黑色素瘤患者的治疗结果方面取得了显著进展.
研究的目的:
- 审查黑色素瘤的历史和当前治疗进展.
- 讨论黑色素瘤治疗中的区域考虑和挑战.
- 探索全球黑色素瘤管理优化新兴策略.
主要方法:
- 关于黑色素瘤治疗的文献综述.
- 对向疗法的分析 (BRAF/MEK 抑制剂).
- 对免疫检查点抑制剂 (PD-1,CTLA-4) 的评估.
主要成果:
- 向疗法和免疫疗法显著改善了黑色素瘤患者的生存率.
- 在亚洲人群中 (状/粘膜黑色素瘤) 抵抗机制和降低疗效仍然是挑战.
- 这些先进的治疗方法已经建立了新的护理标准.
结论:
- 分子向药物和免疫检查点抑制剂代表了黑色素瘤治疗的重大进展.
- 解决耐药性和区域差异对于公平有效的全球黑色素瘤管理至关重要.
- 对新策略的持续研究对于进一步优化全球治疗结果至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

